1 01/01/2025 31/12/2025 2025-12-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-01-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 12690285 2025-01-01 2025-12-31 12690285 2025-12-31 12690285 2024-12-31 12690285 2024-01-01 2024-12-31 12690285 2024-12-31 12690285 2023-12-31 12690285 bus:RegisteredOffice 2025-01-01 2025-12-31 12690285 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 12690285 bus:Director1 2025-01-01 2025-12-31 12690285 core:WithinOneYear 2025-12-31 12690285 core:WithinOneYear 2024-12-31 12690285 bus:Director1 2025-12-31 12690285 bus:Director1 2024-01-01 2024-12-31 12690285 bus:Micro-entities 2025-01-01 2025-12-31 12690285 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 12690285 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 12690285 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 12690285 bus:FullAccounts 2025-01-01 2025-12-31
Company registration number: 12690285
Med Bridge Healthcare Limited
Unaudited filleted financial statements
31 December 2025
Med Bridge Healthcare Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Med Bridge Healthcare Limited
Directors and other information
Director Ms Ozden Ozturk
Company number 12690285
Registered office 12 Highlands Avenue
London
England
W3 6ET
Accountants Ekrem & Co Accountants LLP
Financial and Public Accountants
505 Lordship Lane
London
SE22 8JY
Med Bridge Healthcare Limited
Report to the director on the preparation of the
unaudited statutory financial statements of Med Bridge Healthcare Limited
Year ended 31 December 2025
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31 December 2025 which comprise the statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Ekrem & Co Accountants LLP
Financial and Public Accountants
505 Lordship Lane
London
SE22 8JY
23 April 2026
Med Bridge Healthcare Limited
Statement of financial position
31 December 2025
2025 2024
£ £
Fixed assets 657 903
_______ _______
Current assets 12,778 10,902
Creditors: amounts falling due within one year ( 2,619) ( 1,267)
_______ _______
Net current assets 10,159 9,635
_______ _______
Total assets less current liabilities 10,816 10,538
Accruals and deferred income ( 720) ( 720)
_______ _______
Net assets 10,096 9,818
_______ _______
Capital and reserves 10,096 9,818
_______ _______
Notes to the financial statements
Med Bridge Healthcare Limited
Year ended 31 December 2025
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
2. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2025
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Ms Ozden Ozturk - ( 14,728) 12,444 ( 2,284)
_______ _______ _______ _______
2024
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Ms Ozden Ozturk - ( 17,082) 17,082 -
_______ _______ _______ _______
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 April 2026 , and are signed on behalf of the board by:
Ms Ozden Ozturk
Director
Company registration number: 12690285
The company is a private company limited by shares, registered in England and Wales.